Oncology PracticeCan an app guide cancer treatment decisions during the pandemic?June 9, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic Cancer
Oncology PracticeTKI plus SBRT tops TKI alone for oligometastatic EGFRm NSCLCJune 8, 2020Lung CancerASCO Lung Cancer
Oncology Practice‘A good and peaceful death’: Cancer hospice during the pandemicJune 5, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticePembrolizumab plus EP gives slight PFS edge in ES-SCLCJune 5, 2020Lung CancerASCO Lung Cancer
Oncology Practice‘Promising’ durvalumab results spark phase 3 trial in mesotheliomaJune 4, 2020Lung CancerASCO Lung Cancer
Oncology PracticeGermline testing in advanced cancer can lead to targeted treatmentJune 3, 2020Mixed TopicsBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticePoziotinib provides ‘modest but meaningful’ efficacy in NSCLC subgroupJune 2, 2020Lung Cancer
Oncology PracticeFDA approves ramucirumab-erlotinib combo for metastatic NSCLCJune 1, 2020Lung Cancer
Oncology PracticeTrastuzumab deruxtecan proves active in HER2-mutated NSCLCMay 31, 2020Lung CancerASCO Lung Cancer
Oncology PracticeFirst-line nivolumab plus platinum/etoposide effective in extensive-stage SCLCMay 30, 2020Lung CancerASCO Lung Cancer
Oncology PracticeClinicians still unaware of need for genetic testing in NSCLCMay 29, 2020Lung Cancer
Oncology PracticeAdjuvant osimertinib extends DFS in localized NSCLCMay 28, 2020Lung CancerASCO Lung Cancer
Oncology PracticeActive cancer increases death risk in patients with COVID-19May 28, 2020Patient & Survivor CareBreast CancerLung CancerLymphoma & Plasma Cell DisordersGenitourinary CancerGastroenterologyCOVID-19 Updates
